Showing results (81-90 of 176) with videos related to
Sort By:
Pageof 18
The American Journal of Medicine|January 1, 1978
Granulocytopenia in hospitalized patients: I. Prognostic factors and etiology of feverM J Gurwith, J L Brunton, B A Lank, et al.Reviews of Infectious Diseases|November 1, 1980
Epidemiologic, clinical, laboratory, and therapeutic features of an urban outbreak of chancroid in North AmericaG W Hammond, M Slutchuk, J Scatliff, et al.The Journal of Infectious Diseases|May 1, 1993
Humoral immune response of humans to lipooligosaccharide and outer membrane proteins of Haemophilus ducreyiM J Alfa, N Olson, P Degagne, et al.Archives of Internal Medicine|December 1, 1981
Trimethoprim alone in the treatment and prophylaxis of urinary tract infectionR B Light, A R Ronald, G K Harding, et al.The American Journal of Medicine|January 1, 1978
Granulocytopenia in hospitalized patients. II. A prospective comparison of two antibiotic regimens in the empiric therapy of febrile patientsM Gurwith, J L Brunton, B Lank, et al.The Journal of Infectious Diseases|April 1, 1981
A comparison of the efficacy of nalidixic acid and cephalexin in bacteriuric women and their effect on fecal and periurethral carriage of enterobacteriaceaeJ K Preiksaitis, L Thompson, G K Harding, et al.Antimicrobial Agents and Chemotherapy|July 1, 1987
In vitro activity of ceftriaxone, cefetamet (Ro 15-8074), ceftetrame (Ro 19-5247; T-2588), and fleroxacin (Ro 23-6240; AM-833) versus Neisseria gonorrhoeae and Haemophilus ducreyiN M Le Saux, L A Slaney, F A Plummer, et al.Sexually Transmitted Diseases|November 1, 1992
Use of an adsorption enzyme immunoassay to evaluate the Haemophilus ducreyi specific and cross-reactive humoral immune response of humansM J Alfa, N Olson, P Degagne, et al.The Journal of Infectious Diseases|February 1, 1993
Ceftriaxone no longer predictably cures chancroid in KenyaM Tyndall, M Malisa, F A Plummer, et al.Canadian Medical Association Journal|September 9, 1978
Comparison of silver sulfadiazine and gentamicin for topical prophylaxis against burn wound sepsisC F Snelling, A R Ronald, W R Waters, et al.Pageof 18